safingol has been researched along with Insulin Resistance in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bzdęga, W; Chabowski, A; Harasim-Symbor, E; Hołownia, A; Konstantynowicz-Nowicka, K; Kurzyna, PF | 1 |
Bzdęga, W; Chabowski, A; Harasim-Symbor, E; Konstantynowicz-Nowicka, K; Kołakowski, A; Kurzyna, PF; Żywno, H | 1 |
Adeli, K; Baker, C; Dekker, MJ; Naples, M; Qiu, W; Sacco, J; Samsoondar, J; Zhang, R | 1 |
Chabowski, A; Górski, J; Kurek, K; Mikłosz, A; Żendzian-Piotrowska, M; Łukaszuk, B | 1 |
4 other study(ies) available for safingol and Insulin Resistance
Article | Year |
---|---|
How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
Topics: Animals; Ceramides; Insulin; Insulin Resistance; Liver; Rats; Sphingolipids | 2023 |
Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway.
Topics: Biosynthetic Pathways; Carcinoma, Hepatocellular; Ceramides; Chromatography, High Pressure Liquid; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Insulin; Insulin Resistance; Liver Neoplasms; Models, Biological; Palmitic Acid; Phosphorylation; Sphingosine; Up-Regulation; Vitamin K 2 | 2021 |
Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Topics: Animal Feed; Animals; Apolipoprotein B-100; Cricetinae; Dietary Fats; Disease Models, Animal; Dyslipidemias; Fatty Acids, Monounsaturated; Fructose; Glucose Intolerance; Hepatitis; Immunosuppressive Agents; Insulin Resistance; Lipoproteins, VLDL; Liver; Male; Mesocricetus; Signal Transduction; Sphingolipids; Sphingosine | 2013 |
Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Topics: Animals; Ceramides; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Fatty Acids, Monounsaturated; Glycolysis; Insulin Resistance; Lysophospholipids; Male; Muscle, Skeletal; Oxygen; Rats; Rats, Wistar; Signal Transduction; Sphingolipids; Sphingosine | 2015 |